Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Tirzepatide for Sale > Tirzepatide,Diabetes blood sugar control,Weight loss
Tirzepatide,Diabetes blood sugar control,Weight loss buy - large image1
Tirzepatide,Diabetes blood sugar control,Weight loss buy - image1
Tirzepatide,Diabetes blood sugar control,Weight loss buy - image2
Tirzepatide,Diabetes blood sugar control,Weight loss buy - image3
Tirzepatide,Diabetes blood sugar control,Weight loss buy - image4

Tirzepatide,Diabetes blood sugar control,Weight loss

1847 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Qingdao/Shanghai

Brand:

Shandong SINO

Packaging:

10vials/box

Price valid (until):

2026-04-07

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptide products,Antibiotics,Nutritional supplements,Vitamins,Analgesic

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Shop Tirzepatide,Diabetes blood sugar control,Weight loss-Detailed Image 1

    Shop Tirzepatide,Diabetes blood sugar control,Weight loss-Detailed Image 2

    Tirzepatide is the world's first GLP-1 /GIP dual-receptor agonist polypeptide drug, mainly used for blood glucose control in type 2 diabetes and chronic weight management in adults. Its CAS number is 2023788-19-2.


    I. Mechanism of Action and Core Indications:


    Dual-target synergistic mechanism: Simultaneously activating GLP-1 and GIP receptors. The GLP-1 receptor is responsible for delaying gastric emptying, suppressing appetite, and promoting insulin secretion. GIP receptors promote fat breakdown and enhance energy utilization, dual regulating metabolism. Their effects in blood sugar control and weight loss are superior to those of single-target GLP-1 drugs.

    Approved indications

    Adult type 2 diabetes (diet + exercise assistance to improve blood sugar).

    2. Chronic weight management in adults who are obese (BMI≥28 kg/m²) or overweight (BMI≥24 kg/m²) with weight-related complications (such as hypertension, dyslipidemia, etc.).


    Contraindicated groups: Patients with a history or family history of medullary thyroid carcinoma (MTC), and those with type 2 multiple endocrine tumor syndrome (MEN2). Patients with type 1 diabetes and diabetic ketoacidosis are not recommended to use it.


    The administration method is subcutaneous injection once a week, and it can be administered in the abdomen, thigh or upper arm


    Dose titration starts at 2.5 mg (4-week adaptation period) → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg (maximum dose)


    The hypoglycemic effect reduces HbA1c by 1.8% to 2.3%, which is superior to that of single-target GLP-1 drugs


    A dose of 15 mg can reduce weight by approximately 16-22.5% in a year, which is significantly better than semaglutide


    Common adverse reactions include mild to moderate gastrointestinal reactions (nausea, diarrhea, and vomiting), which are relieved over time with medication

    Shop Tirzepatide,Diabetes blood sugar control,Weight loss-Detailed Image 3

    Shop Tirzepatide,Diabetes blood sugar control,Weight loss-Detailed Image 4

    Shop Tirzepatide,Diabetes blood sugar control,Weight loss-Detailed Image 5

    Shop Tirzepatide,Diabetes blood sugar control,Weight loss-Detailed Image 6



    Storage

    • Storage Conditions:Selank should be stored in a cool, dry place, preferably refrigerated to maintain stability and potency.
    • Stability:When stored properly, Selank remains stable for extended periods. However, it is important to avoid repeated freeze-thaw cycles.
    Moreover, kindly note that we are always providing our customers with Consignment Manufacturing Serivce,  OEM/ODM.


    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Polypeptide

    Characteristics
    Appearance:

    White to off-white

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptide products,Antibiotics,Nutritional supplements,Vitamins,Analgesic

    Location:

    Unit 101, Building 17, Junhe Yungu Industrial Park, Tongji Road, High-Tech Zone, Jining City, Shandong Province, China

    Payment Terms:

    TT against copy of documents,D/P,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    45

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2016

    Certifications:

    Business License

    Shandong Sino Pharmaceutical Technology Co., Ltd. (S.S.P.T.)  is a different kind of pharmaceuticals (both finished medicine products and raw materials), health products, cosmetics and medical supplies company for human needs, focusing on global markets, especially the developing world. Working with the highest levels of government and local distributors alike, we aim to not only expand our business scale and scope but also have a special interest in serving the needs of the end consumer that requires our products the most. To this end, we have a presence in 5 continents with an expanding product range to meet the demand of our main markets.
     
    Moreover, our manufacturing facilities follow strict GMP rules and regulations. We have intergraded all GMP guidelines into internal procedures improving the degree to which results are consistently exceeding expectations. As one of the best pharmaceutical companies in China, we take our ethical obligation to improving access to high quality and affordable WHO essential drugs seriously. This is the ethical basis our company was founded on.
    Consignment Manufacturing, Brand OEM/ODM Service are available.

  • Inquiry History
    1847 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    Tirzepatide CAS 2023788-19-2 99% White powder

    Jun 30, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Tirzepatide 99% white powder 99% powder 2023788-19-2 HSD

    1000 G Jun 27, 2023
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    10  Aug 3, 2023
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    50  Aug 17, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    United States

    Buy Tirzepatide 5mg 10mg 15mg Great Reviews 2023788-19-2 99% powder 001 HD

    1 KG Jul 3, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.